Search bioRxiv⌕ Search

Biology subjects

Minor, W.

Publications and source records attributed to Minor, W..

3 recordsLinked to original sources

Evolutionary Adaptation of Prephenate Dehydrogenases: A regulatory ACT domain acquisition in ecological niche specialization

Bacteria prephenate dehydrogenase (PDH) participates in the metabolic pathway for tyrosine biosynthesis. PDHs within the Bacilaceae phylum contain an ACT domain which enables them to be allosterically regulated by tyrosine. The mechanism via which the ACT domain introduces allostery onto PDH enzymes remains elusive. Furthermore, the evolutionary and biological advantages of ACT domain mediated regulation of metabolic pathways are highly debated. Building on our previous study, in which we solved the crystal structure of a Bacillus antraces ACT-containing PDH and proposed a model for its allosteric regulation by tyrosine, we now present further structural, and functional analyses in support of this model. In this study, we generated truncated PDH protein constructs lacking the ACT domain, determined their crystal structure and evaluated the role of tyrosine in modulating their enzymatic activity. We determined that the truncated PDH remains catalytically active, however, it is no longer allosterically regulated by tyrosine. Comparative structural analysis between the truncated PDH and PDHs naturally lacking the ACT domain that are known to be competitively inhibited by tyrosine revealed only minor changes in a loop region in the prephenate binding site. Attempts to introduce amino acids identified from the competitively inhibited PDH into the truncated construct did not restore tyrosine sensitivity, even at high concentration. This indicates that additional main chain amino acids away from the substrate binding site also contribute competitive inhibition by tyrosine. Analysis of a highly represented phylogenetic tree revealed that ACT containing PDHs are predominantly distributed amongst Firmicute and Actinomycetota. Representative organisms from both groups colonize nutrient limited and extreme environments. This distribution suggests that acquisition of the ACT domain may confer an evolutionary advantage by enabling organisms to efficiently partition chorismate, the end product of the shikimate pathway, for the biosynthesis of tyrosine and other essential aromatic compounds.

biochemistry↗

Transport of Ketoprofen in Mammalian Blood Plasma

Ketoprofen is a popular non-steroidal anti-inflammatory drug (NSAID) transported in the bloodstream mainly by serum albumin (SA). Ketoprofen is known to have multiple side effects and interactions with hundreds of other drugs, which might be related to its vascular transport by SA. Our work reveals that ketoprofen binds to a different subset of drug binding sites on human SA than has been observed for other species, despite the conservation of drug sites between species. We discuss potential reasons for the observed differences in the drugs preferences for particular sites, including ketoprofen binding determinants in mammalian SAs and the effect of fatty acids on drug binding. The presented results show that the SA drug sites to which a particular drug binds cannot be easily predicted based only on a complex of SA from another species and the conservation of drug sites between species.

biophysics↗

Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy

Dexamethasone, a widely used corticosteroid, has recently been reported as the first drug to increase the survival chances of patients with severe COVID-19. Therapeutic agents, including dexamethasone, are mostly transported through the body by binding to serum albumin. Herein, we report the first structure of serum albumin in complex with dexamethasone. We show that it binds to Drug Site 7, which is also the binding site for commonly used nonsteroidal anti-inflammatory drugs and testosterone, suggesting potentially problematic binding competition. This study bridges structural findings with our analysis of publicly available clinical data from Wuhan and suggests that an adjustment of dexamethasone regimen should be considered for patients affected by two major COVID-19 risk-factors: low albumin levels and diabetes. One Sentence SummaryStructure of serum albumin with dexamethasone reveals why the drug may not always help COVID-19 patients.

pharmacology and toxicology↗